The 2019 San Antonio Breast Cancer Symposium will take place from Tuesday, December 10, through Saturday, December 14, 2019, at the Henry B. Gonzalez Convention Center in San Antonio, Texas.
SABCS is a meeting for physicians, oncology nurses, and researchers who specialize in breast malignancies. The program concentrates on the biology and etiology of certain cancers, with presentations that highlight the prevention and diagnosis of disease, as well as the therapeutic interventions (including both standard and novel approaches) that could be considered practice changing.
New research will be presented across a variety of session types, including plenary lectures, mini-symposia, poster presentations, educational sessions, workshops, and other clinically focused forums.
Selected sessions of interest will touch on topics such as the use of machine learning to predict treatment efficacy, comparisons of oral and intravenous routes of administration in metastatic disease, and the ways in which surgical and radiologic interventions could influence the efficacy of subsequent treatments.
Cancer Therapy Advisor’s coverage will provide an overview of the most important and practically relevant breast cancer research and news being released at the meeting. Coverage of data readouts from pivotal trials are expected, including presentations on the findings from HER2CLIMB, SOPHIA, APHINITY (BIG 4-11), PEARL, CARRIERS, SAFIR02-IMMUNO, BRE12-158, NRG-BR005, FeDeriCa, and more.
In addition, you can expect articles covering the important topics across the cancer care continuum that are slated to be discussed in detail at the meeting, including the assessment of long-term survival, the development of new immunotherapies, the expansion of the use of genomics to guide practice decisions, and the clinical applicability of biomarkers.